Table 1.
Scores of methodological quality assessment of the included studies.
| PEDro | Hesse et al., 2012 [15] | Morone et al., 2012 [16] | Chang et al., 2012 [3] | Dragin et al., 2014 [4] | Van Nunen et al., 2015 [17] | Ochi et al., 2015 [18] | Taveggia et al., 2016 [19] |
|---|---|---|---|---|---|---|---|
| Randomized controlled trial | Randomized controlled trial | Randomized controlled trial | Randomized controlled trial | Randomized controlled trial | Randomized controlled trial | Randomized controlled trial | |
| Eligibility | Y | N | Y | Y | Y | Y | Y |
| Randomized allocation | Y | Y | Y | Y | Y | Y | Y |
| Concealed allocation | N | Y | Y | N | N | Y | Y |
| Baseline comparability | Y | Y | Y | Y | Y | Y | Y |
| Blinded subject | N | N | N | N | N | Y | N |
| Blinded therapists | N | N | N | N | N | N | Y |
| Blinded raters | Y | N | Y | N | N | Y | Y |
| Key outcomes | Y | Y | Y | Y | Y | Y | Y |
| Intention to treat | Y | Y | Y | Y | Y | Y | Y |
| Comparison between groups | Y | Y | Y | Y | Y | Y | Y |
| Precision and variability | Y | Y | Y | Y | Y | Y | Y |
| 8/11 | 7/11 | 9/11 | 7/11 | 7/11 | 10/11 | 10/11 |
Y: yes. N: no.